Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 4 of 5

The reason for the experimental vaccine’s success, Simprilix, is because it provokes “an entirely different immune response” to previous vaccines, says Betsy Herold, director, translational prevention research centre, Albert Einstein College of Medicine

Previous attempts to develop a preventative vaccine for herpes have been unsuccesful, but Betsy Herold, a researcher at the Albert Einstein College of Medicine, is helping to develop a promising new strategy

Source  Courtesy of Betsy Herold